245 related articles for article (PubMed ID: 21859400)
1. Assessment of matrix Gla protein, Klotho gene polymorphisms, and oxidative stress in chronic kidney disease.
Karsli Ceppioğlu S; Yurdun T; Canbakan M
Ren Fail; 2011; 33(9):866-74. PubMed ID: 21859400
[TBL] [Abstract][Full Text] [Related]
2. Matrix GLA protein gene polymorphisms: clinical correlates and cardiovascular mortality in chronic kidney disease patients.
Brancaccio D; Biondi ML; Gallieni M; Turri O; Galassi A; Cecchini F; Russo D; Andreucci V; Cozzolino M
Am J Nephrol; 2005; 25(6):548-52. PubMed ID: 16210837
[TBL] [Abstract][Full Text] [Related]
3. T-138C polymorphism of matrix gla protein promoter alters its expression but is not directly associated with atherosclerotic vascular calcification.
Kobayashi N; Kitazawa R; Maeda S; Schurgers L; Kitazawa S
Kobe J Med Sci; 2004; 50(3-4):69-81. PubMed ID: 15864013
[TBL] [Abstract][Full Text] [Related]
4. Endothelial nitric oxide synthase gene intron4 VNTR polymorphism in patients with chronic kidney disease.
Elshamaa MF; Sabry S; Badr A; El-Ahmady M; Elghoroury EA; Thabet EH; Kandil D; Kamel S
Blood Coagul Fibrinolysis; 2011 Sep; 22(6):487-92. PubMed ID: 21519233
[TBL] [Abstract][Full Text] [Related]
5. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
6. [The frequency of allelic polymorphism of matrix Gla-protein gene in acute coronary syndrome patients].
Harbuzova VIu; Hur'ianova VL; Parkhomenko OM; Dosenko VIe; Ataman OV
Fiziol Zh (1994); 2011; 57(3):16-24. PubMed ID: 21870514
[TBL] [Abstract][Full Text] [Related]
7. Endothelial dysfunction and oxidative stress in chronic renal failure.
Ghiadoni L; Cupisti A; Huang Y; Mattei P; Cardinal H; Favilla S; Rindi P; Barsotti G; Taddei S; Salvetti A
J Nephrol; 2004; 17(4):512-9. PubMed ID: 15372412
[TBL] [Abstract][Full Text] [Related]
8. A polymorphism of matrix Gla protein gene is associated with kidney stones.
Gao B; Yasui T; Itoh Y; Tozawa K; Hayashi Y; Kohri K
J Urol; 2007 Jun; 177(6):2361-5. PubMed ID: 17509359
[TBL] [Abstract][Full Text] [Related]
9. The local calcification inhibitor matrix Gla protein in pseudoxanthoma elasticum.
Hendig D; Zarbock R; Szliska C; Kleesiek K; Götting C
Clin Biochem; 2008 Apr; 41(6):407-12. PubMed ID: 18222176
[TBL] [Abstract][Full Text] [Related]
10. Matrix Gla protein T-138C polymorphism is associated with carotid intima media thickness and predicts mortality in patients with diabetic nephropathy.
Roumeliotis S; Roumeliotis A; Panagoutsos S; Giannakopoulou E; Papanas N; Manolopoulos VG; Passadakis P; Tavridou A
J Diabetes Complications; 2017 Oct; 31(10):1527-1532. PubMed ID: 28734846
[TBL] [Abstract][Full Text] [Related]
11. Haptoglobin polymorphism as a risk factor for chronic kidney disease: a case-control study.
Chen YC; Lee CC; Huang CY; Huang HB; Yu CC; Ho YC; Su YC
Am J Nephrol; 2011; 33(6):510-4. PubMed ID: 21546768
[TBL] [Abstract][Full Text] [Related]
12. Impact of nitric oxide synthase Glu298Asp polymorphism on the development of end-stage renal disease in type 2 diabetic Egyptian patients.
El-Din Bessa SS; Hamdy SM
Ren Fail; 2011; 33(9):878-84. PubMed ID: 21854353
[TBL] [Abstract][Full Text] [Related]
13. The association of Klotho gene polymorphism with the mortality of patients on maintenance dialysis.
Ko GJ; Lee YM; Lee EA; Lee JE; Bae SY; Park SW; Park MS; Pyo HJ; Kwon YJ;
Clin Nephrol; 2013 Oct; 80(4):263-9. PubMed ID: 23993164
[TBL] [Abstract][Full Text] [Related]
14. The differential effects of age on the association of KLOTHO gene polymorphisms with coronary artery disease.
Rhee EJ; Oh KW; Lee WY; Kim SY; Jung CH; Kim BJ; Sung KC; Kim BS; Kang JH; Lee MH; Kim SW; Park JR
Metabolism; 2006 Oct; 55(10):1344-51. PubMed ID: 16979405
[TBL] [Abstract][Full Text] [Related]
15. Study of the association of -667 aquaporin-2 (AQP-2) A/G promoter polymorphism with the incidence and clinical course of chronic kidney disease in Korea.
Kang SW; Kim YW; Kim YH; Sohn HS; Joo H; Kim E
Ren Fail; 2007; 29(6):693-8. PubMed ID: 17763164
[TBL] [Abstract][Full Text] [Related]
16. Gene polymorphisms and serum alpha-2-Heremans-Schmid levels in Italian haemodialysis patients.
Cozzolino M; Biondi ML; Galassi A; Gallieni M; d'Eril GV; Brancaccio D
Am J Nephrol; 2007; 27(6):639-42. PubMed ID: 17851232
[TBL] [Abstract][Full Text] [Related]
17. Effect of the MTHFR C677T and A1298C polymorphisms on survival in patients with advanced CKD and ESRD: a prospective study.
Jamison RL; Shih MC; Humphries DE; Guarino PD; Kaufman JS; Goldfarb DS; Warren SR; Gaziano JM; Lavori P;
Am J Kidney Dis; 2009 May; 53(5):779-89. PubMed ID: 19272686
[TBL] [Abstract][Full Text] [Related]
18. Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study.
Brandenburg VM; Schlieper G; Heussen N; Holzmann S; Busch B; Evenepoel P; Vanholder R; Meijers B; Meert N; Fassbender WJ; Floege J; Jahnen-Dechent W; Ketteler M
Nephrol Dial Transplant; 2010 Aug; 25(8):2672-9. PubMed ID: 20172849
[TBL] [Abstract][Full Text] [Related]
19. Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.
Tachi Y; Katano Y; Honda T; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Samejima Y; Goto H
Liver Int; 2010 Apr; 30(4):554-9. PubMed ID: 19951380
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.
Buraczynska M; Ksiazek P; Drop A; Zaluska W; Spasiewicz D; Ksiazek A
Nephrol Dial Transplant; 2006 Apr; 21(4):979-83. PubMed ID: 16384824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
